Replating Protocol for Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Arzuhan Koc1,2, Esra Cagavi3,4,5

  • 1Regenerative and Restorative Medicine Research Center (REMER), Research Institute for Health Sciences and Technologies (SABITA), Istanbul Medipol University, Istanbul, Turkey.

Insights

Optimized protocols for replating human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) ensure high viability. These methods effectively generate single-cell or cluster hiPSC-CM cultures for cardiac research.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Biology
  • Biotechnology

Background:

  • Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a renewable source for cardiac research.
  • Challenges exist in obtaining hiPSC-CM cultures in desired formats (single-cell, monolayer, 3D clusters) for downstream applications.

Purpose of the Study:

  • To develop and optimize replating strategies for hiPSC-CMs.
  • To evaluate various dissociation reagents and matrix coatings for effective reseeding.

Main Methods:

  • Dissociation of hiPSC-CMs using collagenase A&B, Collagenase II, TrypLE, and EDTA.
  • Reseding of dissociated hiPSC-CMs on matrix materials including fibronectin, laminin, iMatrix, Matrigel, and Geltrex.

Main Results:

  • Defined optimized protocols for hiPSC-CM dissociation and reseeding.
  • Achieved high viability of reseeding hiPSC-CMs.
  • Successfully generated single-cell or cluster-containing hiPSC-CM cultures.

Conclusions:

  • Optimized replating strategies are critical for generating functional hiPSC-CM cultures.
  • The described methods provide effective means to obtain hiPSC-CMs in desired formats for diverse research applications.
  • These protocols enhance the utility of hiPSC-CMs in basic and translational cardiac research.

Related Concept Videos